Population Pharmacokineties of Mycophenolic Acid in Chinese Adult Renal Transplant Patients

焦正,张明,梁惠琪,郁韵秋,钟明康,陆伟跃
DOI: https://doi.org/10.3321/j.issn:1001-2494.2007.01.017
2007-01-01
Abstract:OBJECTIVE To characterize the population pharmacokinetics(PK) of mycophenolic acid(MPA) in Chinese adult renal transplant patients during the first three months after transplantation.METHODS Fifty-two Adult renal transplant recipients,who were orally administered with mycophenolate mofetil,cyclosporine and corticosteroids,were enrolled in this study.Totally 560 blood samples were collected from their MPA PK profiles with relating demographical,pathological and laboratory test results.Nonlinear mixed effect modeling was employed to establish the population PK model of MPA.Age,gender,height,weight,dose,serum creatinine,co-administraed drugs,post-operation day and 11 single nucleotide polymorphisms in UGT1A9 promoter area etc,were screened as covariates.The final PK model was validated using 200 bootstrap techniques.RESULTS A two-compartment model with first-order absorption and elimination provided the best fitting.First order conditional estimation was employed as the algorithm.Total body weight and time after transplantation were identified as covariates influencing the clearance of MPA.The final population PK model for MPA was listed below:CL/F(L·h~(-1))=0.554·TBW(kg)·(1-e~(-1.14·POD)).The final population model yielded mean population CL/F value of 31 L·h~(-1),which was consistent with those of previous reports conducted in Caucasians.Bootstrapped results showed close agreement between pairs of bootstrapped and final model parameter estimates.CONCLUSION It is the first time that population PK parameters for MPA are determined in Chinese renal transplant recipients.These can be used to achieve specific target MPA concentrations or areas under the concentration-time curve with the Bayesian methods.
What problem does this paper attempt to address?